GSK plc (GSK.L) PEG Ratio

Price: $1485
Market Cap: $60.44B
Avg Volume: 8.81M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.286
52W Range: $1282.5-1823.5
Website: GSK plc

PEG Ratio Summary

  • GSK plc's trailing twelve month (TTM) PEG ratio is 7.29.
  • GSK plc's annual PEG ratio as of today is -0.44.
  • GSK plc's quarterly PEG ratio is -0.04.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess GSK plc's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: 21.32
    • Quarterly: 33.15
    • TTM: 23.51
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 1.75
    • Quarterly: 6.76
    • TTM: 1.93
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: 4.02
    • Quarterly: 4.02
    • TTM: 4.43
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: 8.38
    • Quarterly: 23.57
    • TTM: 9.62

These metrics provide insights into GSK plc's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

7.29

Annual PEG Ratio

-0.44

Quarterly PEG Ratio

-0.04

GSK plc Historical PEG Ratio

1.001.000.000.00-1.00-1.00-2.00-2.00-3.00-3.00PEG Ratio-0.440.00-1.07-2.440.410.560.120.55-0.760.03-0.400.51-0.950.05-0.44201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025

Historical P/E Ratio

80.0080.0060.0060.0040.0040.0020.0020.000.000.00P/E Ratio21.3211.9211.7611.859.3915.3116.3434.0867.266.3619.4011.5711.6111.3631.18201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025

Historical P/S Ratio

3.003.002.002.001.001.000.000.00P/S Ratio1.751.941.971.521.582.111.921.732.202.242.322.372.002.181.79201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025

Historical P/B Ratio

200.00200.000.000.00-200.00-200.00-400.00-400.00-600.00-600.00-800.00-800.00P/B Ratio4.024.405.463.453.705.9313.58-767.8654.5710.4812.548.999.127.445.73201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025

Historical P/CF Ratio

25.0025.0020.0020.0015.0015.0010.0010.005.005.000.000.00P/CF Ratio8.388.687.826.546.398.877.037.559.4420.8610.338.7112.119.577.50201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025

GSK plc Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2024 -0.44 21.32 1.75 4.02 8.38
2023 0.00 11.92 1.94 4.40 8.68
2022 -1.07 11.76 1.97 5.46 7.82
2021 -2.44 11.85 1.52 3.45 6.54
2020 0.41 9.39 1.58 3.70 6.39
2019 0.56 15.31 2.11 5.93 8.87
2018 0.12 16.34 1.92 13.58 7.03
2017 0.55 34.08 1.73 -767.86 7.55
2016 -0.76 67.26 2.20 54.57 9.44
2015 0.03 6.36 2.24 10.48 20.86
2014 -0.40 19.40 2.32 12.54 10.33
2013 0.51 11.57 2.37 8.99 8.71
2012 -0.95 11.61 2.00 9.12 12.11
2011 0.05 11.36 2.18 7.44 9.57
2010 -0.44 31.18 1.79 5.73 7.50

Related Metrics

Explore detailed financial metrics and analysis for GSK.L.